NHF is the 4th largest private health business in Australia covering both residents and also international students and workers – a larger population equals more potential customers. Revenues and margins declined during COVID, both are now rebounding rapidly, and we see upside risk to consensus if the company can achieve a full normalisation of volumes and margins.
- We like the risk/reward toward NHF following its recent 14% pullback.
MM likes NHF under $7.50
Add To Hit List
